Barinthus Biotherapeutics
BRNS
$2.40
Share price
1.65%
Change (1 day)
-4.42%
Change (1 year)
Categories
Barinthus Biotherapeutics (BRNS) - Cash on Hand
Cash on Hand as of December 2023 : $0.14 B
According to Barinthus Biotherapeutics's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Barinthus Biotherapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.19 B | -9.19% |
| 2021-12-31 | $0.21 B | 394.74% |
| 2020-12-31 | $43.26 M | 278.46% |
| 2019-12-31 | $11.43 M |